【News！】
new order | old order
An article about our company was published in the Mainichi Shimbun.
Presentation movie uploaded at Antibody Engineering & Therapeutics 2023
RevolKa raises ￥150 million series A extension
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
Started contract service for highly functional antibodies using “aiProtein®”
Adopted for NEDO Development of Quantum/AI Hybrid Use-Case Technologies in Cyber-Physical Space
Presenting at The Antibody Society of Japan
Presenting at Antibody Engineering & Therapeutics
Presenting at JBA
LATEST ARTICLE
ARCHIVE
- 2024/04 (2)
- 2024/03 (1)
- 2024/02 (4)
- 2024/01 (2)
- 2023/12 (2)
- 2023/11 (1)
- 2023/10 (2)
- 2023/09 (2)
- 2023/08 (2)
- 2023/06 (3)
- 2023/05 (1)
- 2023/04 (3)
CATEGORY
View allTAG